首頁 > 市場調查報告書 > 製藥

蝨子治療市場規模、佔有率和成長分析（按產品類型、劑型、給藥途徑、症狀、劑量形式、分銷管道和地區分類）—產業預測（2026-2033 年）

市場調查報告書

商品編碼

1897896

蝨子治療市場規模、佔有率和成長分析（按產品類型、劑型、給藥途徑、症狀、劑量形式、分銷管道和地區分類）—產業預測（2026-2033 年）

Lice Treatment Market Size, Share, and Growth Analysis, By Product Type (OTC products, Prescription medications), By Type, By Route of Administration, By Condition, By Dosage Form, By Distribution Channel, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月22日 | 出版商:

SkyQuest | 英文 193 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，全球蝨子治療市場規模將達到 23.5 億美元，到 2025 年將達到 25.1 億美元，到 2033 年將達到 42.9 億美元，預測期（2026-2033 年）的複合年成長率為 6.9%。

由於虱病不斷上升，全球除蝨市場預計將迎來顯著成長，尤其是在學校人滿為患和社區人際交往密切等因素的影響下。非處方藥的便利性和產品配方的進步正在推動市場進一步成長。此外，人們對傳統殺蟲劑類產品神經毒性的擔憂也產生了重大影響，促使消費者對天然無毒的治療方法產生需求。線上零售平台的興起也提高了治療方法的可及性，使市場參與者受益。然而，蝨子對化學治療的抗藥性日益增強、有害的副作用、低收入地區獲取途徑有限以及與蝨子感染相關的社會污名等挑戰，可能會在短期內阻礙市場滲透和成長。

全球蝨子治療市場促進因素

全球除蝨產品市場成長的主要驅動力在於治療配方方面的創新，這些創新提高了治療效果和使用者安全性。現代產品不含殺蟲劑，採用矽酮溶液，以物理方式固定蝨子，最大限度地減少對神經毒素的依賴，並有效解決抗藥性問題。這些現代療法無味、無刺激性，且所需時間更短，顯著提升了使用者體驗。這些進步提高了消費者的信任度和滿意度，從而增加了重複購買率，並為除蝨產品市場帶來了光明的前景。

全球蝨子治療市場面臨的限制因素

由於蝨子對傳統治療方法的抗藥性日益增強，全球除蝨市場正面臨嚴峻挑戰。過度使用以往備受信賴的化學製劑，例如Permethrin和除蟲菊酯，降低了其療效，導致治療失敗。這種抗藥性不僅令消費者感到失望，也削弱了消費者對知名品牌的信任，最終影響了復購率。此外，對多種化學療法具有抗藥性的「超級蝨」的出現，進一步加劇了市場挑戰。因此，市場對非化學替代療法的需求日益成長，這阻礙了除蝨產業的成長。

全球蝨子治療市場趨勢

全球除蝨市場正經歷著向預防保健的顯著轉變，消費者越來越重視採取積極措施預防蝨子感染。這一發展趨勢的特點是，消費者對預防性產品的需求不斷成長，例如添加了迷迭香和尤加利等具有天然驅蝨功效的精油的特製洗髮精、噴霧劑和梳子。家長和教育機構正在採用這些預防措施，以確保創造無蝨環境，從而將市場範圍從單純的被動治療擴展到更全面的預防。這種對產品長期使用的重視反映了人們對蝨子預防意識的不斷提高，最終將改變消費者的行為並推動產業創新。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Johnson & Johnson Services, Inc.（USA）
Reckitt Benckiser Group plc（UK）
Perrigo Company plc（Ireland）
Prestige Consumer Healthcare Inc.（USA）
Sanofi SA（France）
GlaxoSmithKline（GSK）plc（UK）
Teva Pharmaceutical Industries Ltd.（Israel）
Pfizer Inc.（USA）
F. Hoffmann-La Roche Ltd.（Switzerland）
Sun Pharmaceutical Industries Ltd.（India）
ParaPRO LLC.（USA）
Alliance Pharma PLC（UK）
Arbor Pharmaceuticals, LLC.（USA）
Oystershell Consumer Health（Belgium）
Taro Pharmaceuticals（Canada）
ICB PHARMA（Poland）
Lice Clinics of America（USA）

結論與建議

簡介目錄

Product Code: SQMIG35D2312

Global Lice Treatment Market size was valued at USD 2.35 Billion in 2024 and is poised to grow from USD 2.51 Billion in 2025 to USD 4.29 Billion by 2033, growing at a CAGR of 6.9% during the forecast period (2026-2033).

The global lice treatment market is poised for significant growth driven by an increasing incidence of lice infestations, particularly due to factors like overcrowded schools and close community interactions. The convenience of over-the-counter treatments and advancements in product formulations further enhance market opportunities. Additionally, there is a rising demand for natural and non-toxic treatment options, largely influenced by concerns over the neurotoxicity associated with conventional pesticide-based products. The growth of online retail platforms has also improved accessibility of treatments, benefitting market players. However, challenges such as the rising resistance of lice to chemical treatments, adverse side effects, limited access in low-income regions, and social stigma surrounding infestations may hinder market penetration and growth in the near future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Lice Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Lice Treatment Market Segments Analysis

Global Lice Treatment Market is segmented by Product Type, Type, Route of Administration, Condition, Dosage Form, Distribution Channel and region. Based on Product Type, the market is segmented into OTC products and Prescription medications. Based on Type, the market is segmented into Branded and Generic. Based on Route of Administration, the market is segmented into Oral and Topical. Based on Condition, the market is segmented into Pediculosis capitis, Pediculosis corporis and Pediculosis pubis. Based on Dosage Form, the market is segmented into Tablets, Shampoos, Lotions, Cream and Other dosage forms. Based on Distribution Channel, the market is segmented into Hospital pharmacies, Retail pharmacies and Other distribution channels. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Lice Treatment Market

The growth of the Global Lice Treatment market is significantly propelled by innovations in treatment formulations that enhance both efficacy and user safety. Modern products now feature non-pesticide and silicone-based solutions that immobilize lice physically, minimizing the reliance on neurotoxins and addressing resistance issues. These contemporary treatments are designed to be odorless and less irritating, while also requiring shorter application times, which greatly improves the overall user experience. As a result of these advancements, consumers develop greater trust and satisfaction, leading to increased repeat purchases and a positive outlook for the lice treatment market moving forward.

Restraints in the Global Lice Treatment Market

The Global Lice Treatment market faces significant challenges due to the increasing resistance of lice to traditional treatments. Previously reliable chemical agents such as permethrin and pyrethrin have seen diminished effectiveness due to over-application, leading to instances of treatment failure. This resistance not only frustrates consumers but also erodes trust in established brands, ultimately affecting repeat purchases. Additionally, the emergence of "super lice," which resist multiple chemical treatments, compounds the difficulties within the market. Consequently, there is a growing demand for alternative non-chemical solutions, which has impeded the growth of the lice treatment industry.

Market Trends of the Global Lice Treatment Market

The Global Lice Treatment market is witnessing a notable shift toward preventive care, as consumers increasingly prioritize proactive strategies to thwart lice infestations. This evolving trend is characterized by heightened demand for preventive products, including specially formulated shampoos, sprays, and combs infused with natural lice-repelling essential oils like rosemary and eucalyptus. Parents and educational institutions are adopting these preventive measures to ensure a lice-free environment, thereby broadening the market's scope beyond mere reactive treatments. This emphasis on long-term product usage reflects a growing awareness of lice prevention, ultimately transforming consumer behavior and driving innovation within the industry.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Lice Treatment Market Size by Product Type & CAGR (2026-2033)

Market Overview
OTC products
- Permethrin
- Pyrethrin
- Other OTC products
Prescription medications
- Ivermectin
- Spinosad
- Malathion
- Other prescription medications

Global Lice Treatment Market Size by Type & CAGR (2026-2033)

Market Overview
Branded
Generic

Global Lice Treatment Market Size by Route of Administration & CAGR (2026-2033)

Market Overview
Oral
Topical

Global Lice Treatment Market Size by Condition & CAGR (2026-2033)

Market Overview
Pediculosis capitis
Pediculosis corporis
Pediculosis pubis

Global Lice Treatment Market Size by Dosage Form & CAGR (2026-2033)

Market Overview
Tablets
Shampoos
Lotions
Cream
Other dosage forms

Global Lice Treatment Market Size by Distribution Channel & CAGR (2026-2033)

Market Overview
Hospital pharmacies
Retail pharmacies
Other distribution channels

Global Lice Treatment Market Size & CAGR (2026-2033)

North America (Product Type, Type, Route of Administration, Condition, Dosage Form, Distribution Channel)
- US
- Canada
Europe (Product Type, Type, Route of Administration, Condition, Dosage Form, Distribution Channel)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Type, Route of Administration, Condition, Dosage Form, Distribution Channel)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Type, Route of Administration, Condition, Dosage Form, Distribution Channel)
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Type, Route of Administration, Condition, Dosage Form, Distribution Channel)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Johnson & Johnson Services, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Reckitt Benckiser Group plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Perrigo Company plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Prestige Consumer Healthcare Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi S.A. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline (GSK) plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teva Pharmaceutical Industries Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sun Pharmaceutical Industries Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ParaPRO LLC. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alliance Pharma PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Arbor Pharmaceuticals, LLC. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Oystershell Consumer Health (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Taro Pharmaceuticals (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ICB PHARMA (Poland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lice Clinics of America (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments